Skip to main content
. 2022 Nov 24;15:90. doi: 10.1186/s40545-022-00492-2

Table 2.

Implementation of functions assessed

Function # Sub-indicators Implementation of sub-indicators
Fully Partially Ongoing Not
Registration and marketing authorization (MA) 35 29 (83%) 4 (11%) 0 (0%) 2 (6%)
Laboratory testing (LT) 28 23 (82%) 0 (0%) 2 (7%) 3 (11%)
Licensing establishments (LI) 19 15 (79%) 0 (0%) 1 (5%) 3 (16%)
Vigilance (VL) 26 20 (77%) 4 (15%) 0 (0%) 2 (8%)
Market Surveillance and Control (MC) 27 20 (74%) 2 (7%) 0 (0%) 5 (19%)
Clinical Trials Oversight (CT) 30 19 (63%) 3 (10%) 5 (17%) 3 (10%)
National Regulatory System (RS) 60 37 (62%) 4 (6%) 0 (0%) 19 (32%)
Regulatory inspection (RI) 26 16 (62%) 0 (0%) 1 (4%) 9 (34%)